{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:54:33Z","timestamp":1649134473658},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T00:00:00Z","timestamp":1342569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00393-012-0989-5","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T11:21:27Z","timestamp":1342524087000},"page":"515-517","source":"Crossref","is-referenced-by-count":0,"title":["Therapierefrakt\u00e4re Polyarthritis und Fieber"],"prefix":"10.1007","volume":"71","author":[{"given":"M.","family":"Licht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Kyank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kneitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,18]]},"reference":[{"key":"989_CR1","first-page":"181","volume":"15","author":"Herlin","year":"2010","unstructured":"Herlin T (2010) Tocilizumab: the evidence for its place in the treatment of juvenile idiopathic arthritis. Core Evid 15(4):181\u2013189","journal-title":"Core Evid"},{"key":"989_CR2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet 377(9783):2138\u20132149","journal-title":"Lancet"},{"key":"989_CR3","doi-asserted-by":"crossref","first-page":"c6434","DOI":"10.1136\/bmj.c6434","volume":"341","author":"Prince","year":"2010","unstructured":"Prince FH, Otten MH, Suijlekom-Smit LW van (2010) Diagnosis and management of juvenile idiopathic arthritis. BMJ 341:c6434","journal-title":"BMJ"},{"key":"989_CR4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M et al (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 371(9617):998\u20131006","journal-title":"Lancet"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-0989-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-012-0989-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-0989-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:36:10Z","timestamp":1559046970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-012-0989-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,18]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s00393-012-0989-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,18]]}}}